Centessa Pharmaceuticals plc American Depositary Receipt (260)
Market Closed
29 Jun, 20:00
XFRA 
€
34. 60
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
270 Volume
- Eps
€ 34.6
Previous Close Want to track 260 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
260 Earnings Reports FAQ
What is the earnings per share (EPS) for 260?
EPS data for 260 is currently not available, as Centessa Pharmaceuticals plc American Depositary Receipt has not reported recent earnings.
What is the company's earnings growth rate?
Centessa Pharmaceuticals plc American Depositary Receipt has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Centessa Pharmaceuticals plc American Depositary Receipt has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Centessa Pharmaceuticals plc American Depositary Receipt are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 260 at this time, as Centessa Pharmaceuticals plc American Depositary Receipt has no recent EPS data to calculate it.
